Schematic of how a «chimeric autoantibody receptor,» or CAAR, that displays fragments of the autoantigen Dsg3 helps fight an autoimmune disease
called pemphigus vulgaris, a condition in which a patient's own immune cells attack Dsg3, which normally adheres skin cells.
This is a schematic of how a «chimeric autoantibody receptor,» or CAAR, that displays fragments of the autoantigen Dsg3 helps fight an autoimmune disease
called pemphigus vulgaris, a condition in which a patient's own immune cells attack Dsg3, which normally adheres skin cells.